GetTopicDetailResponse(id=7b791904e5b, topicName=Zilucoplan, introduction=Zilucoplan, content=null, image=null, comments=3, allHits=1474, url=https://h5.medsci.cn/topic?id=19047, type=0, isShow=1, status=1, isAdmin=null, adminId=1, adminEncryptionId=1eae1, adminName=小M, createdBy=null, createdName=, createdAvatar=, createdTime=Fri May 29 21:19:53 CST 2020, time=2020-05-29, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=81058, tagList=[TagDto(tagId=81058, tagName=Zilucoplan)], ipAttribution=, topicAdmin=1, lengthMark=0)
[GetTopicListResponse(id=2260461, encodeId=7bd0226046119, content=<a href='/topic/show?id=eb418106018' target=_blank style='color:#2F92EE;'>#肌萎縮側索硬化癥#</a> <a href='/topic/show?id=7b791904e5b' target=_blank style='color:#2F92EE;'>#Zilucoplan#</a>, objectTitle=《JAMA Network Open》：Zilucoplan在肌萎縮側索硬化癥中的療效和安全性, objectType=article, longId=872036, objectId=76448e203613, topicUrl=null, isHasObj=0, objectCover=, objectUrl=/article/show_article.do?id=76448e203613, replyNumber=0, likeNumber=37, createdTime=2025-04-14, rootId=0, userName=梅斯管理員, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=76448e203613, moduleTitle=《JAMA Network Open》：Zilucoplan在肌萎縮側索硬化癥中的療效和安全性, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=76448e203613)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2130264, encodeId=b51f213026423, content=<a href='/topic/show?id=7b791904e5b' target=_blank style='color:#2F92EE;'>#Zilucoplan#</a>治療顯示了<a href='/topic/show?id=910e959e0c9' target=_blank style='color:#2F92EE;'>#重癥肌無力#</a>特異性療效的快速和有臨床意義的改善，具有良好的安全性，并且耐受性良好。有潛力！期待！, objectTitle=Lancet Neuro: RAISE研究公布重癥肌無力在研藥物zilucoplan的3期治療結果, objectType=article, longId=770326, objectId=013ae703266a, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20230326/1679868111251_4754896.png, objectUrl=/article/show_article.do?id=013ae703266a, replyNumber=0, likeNumber=130, createdTime=2023-05-05, rootId=0, userName=俠膽醫(yī)心, userId=f63e4754896, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=013ae703266a, moduleTitle=Lancet Neuro: RAISE研究公布重癥肌無力在研藥物zilucoplan的3期治療結果, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=013ae703266a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2130266, encodeId=8d4d2130266b6, content=<a href='/topic/show?id=a9f7106134c3' target=_blank style='color:#2F92EE;'>#羅扎諾利珠單抗#</a>都對<a href='/topic/show?id=5748106135ce' target=_blank style='color:#2F92EE;'>#全身性肌無力#</a>患者的患者報告和研究者評估的結果有臨床意義的改善。<a href='/topic/show?id=7b791904e5b' target=_blank style='color:#2F92EE;'>#Zilucoplan#</a>治療顯示了<a href='/topic/show?id=910e959e0c9' target=_blank style='color:#2F92EE;'>#重癥肌無力#</a>特異性療效的快速和有臨床意義的改善，新藥未來可能越來越多！, objectTitle=Lancet子刊：羅扎諾利珠單抗在全身性肌無力患者中的安全性和有效性研究, objectType=article, longId=770323, objectId=d81ce7032384, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20230326/1679868140278_4754896.png, objectUrl=/article/show_article.do?id=d81ce7032384, replyNumber=0, likeNumber=140, createdTime=2023-05-05, rootId=0, userName=俠膽醫(yī)心, userId=f63e4754896, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=d81ce7032384, moduleTitle=Lancet子刊：羅扎諾利珠單抗在全身性肌無力患者中的安全性和有效性研究, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=d81ce7032384)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2077001, encodeId=e71220e7001f8, content=<a href='/topic/show?id=7b791904e5b' target=_blank style='color:#2F92EE;'>#Zilucoplan#</a>, objectTitle=Ra Pharma宣布Zilucoplan在腎功能不全患者中的藥代動力學結果, objectType=article, longId=149962, objectId=b17c149962ab, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b17c149962ab, replyNumber=0, likeNumber=73, createdTime=2018-11-02, rootId=0, userName=新生兒張玉軍, userId=38fd2500059, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b17c149962ab, moduleTitle=Ra Pharma宣布Zilucoplan在腎功能不全患者中的藥代動力學結果, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=b17c149962ab)], followStatus=false, userIsMember=false, type=1, lengthMark=0)]
梅斯話題小助手
2020-05-29
